Calcipotriene/betamethasone dipropionate aerosol foam regulatory update

Leo Pharma submitted an NDA to FDA for calcipotriene/betamethasone dipropionate aerosol foam to treat psoriasis vulgaris. The product is an aerosol foam formulation of a fixed-dose combination of 0.00...